NorthView Acquisition Corporation
Status: Live Deal
U=S+W/2+R
W=S@11.50
R=S/10
| IPO Proceeds, $M | $189.75M |
|---|---|
| IPO Date | Dec 20, 2021 |
| CEO | Jack Stover |
| Left Lead | I-Bankers Securities |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 15 + 9 + 3 + 6 + 6 |
| IPO Sector |
Healthcare
Businesses that are focused on healthcare innovation |
| IPO Geography | Global |
| Target Company | Profusa |
| Deal Announced | Nov 7, 2022 |
| Deal Size, $M | $270.10M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Sep 19, 2024 |
NVAC
NVACU
NVACW
NVACR
| Price | $11.71 |
|---|---|
| Last closing price | $11.71 |
| H/L, today | $11.71 / $11.71 |
| H/L, 52-week | $9.95 / $10.85 |
| Volume, today | 1 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on NorthView Acquisition Corporation:
- Structure and cap table
- 5 directors & officers
- 37 filings and events
- 4 underwriters
- 3 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jack Stover | 68 | Co-Founder, Director, Chief Executive Officer |
| Fred Knechtel | 61 | Co-Founder, Director, Chief Financial Officer |
| Peter O’Rourke | 49 | Chairman of the Board, Independent Director |
| Ed Johnson | 61 | Independent Director |
| Lauren Chung | 48 | Independent Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| I-Bankers Securities | BR | 9,200,000 | units |
| Dawson James | 2,000,000 | ||
| EarlyBirdCapital | 5,000,000 | ||
| I-Bankers Securities | 300,000 | ||
| 16,500,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 3.68 | % |
Sign in to view more advisor data.